Taplitumomab paptox

{{Short description|Monoclonal antibody}}

{{Drugbox

| Verifiedfields = changed

| verifiedrevid = 470477572

| image =

| type = mab

| mab_type = mab

| source = o

| target = CD19

| tradename =

| pregnancy_AU =

| pregnancy_US =

| pregnancy_category =

| legal_AU =

| legal_CA =

| legal_UK =

| legal_US =

| legal_status =

| routes_of_administration =

| bioavailability =

| protein_bound =

| metabolism =

| elimination_half-life =

| excretion =

| CAS_number_Ref = {{cascite|correct|CAS}}

| CAS_number = 235428-87-2

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = AR3ULB33ZZ

| ATC_prefix = none

| ATC_suffix =

| PubChem =

| DrugBank_Ref = {{drugbankcite|correct|drugbank}}

| DrugBank =

| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}

| ChemSpiderID = none

| chemical_formula =

| molecular_weight =

}}

Taplitumomab paptox is a mouse monoclonal antibody. The antibody itself, taplitumomab, is linked to the protein PAP, an antiviral from Phytolacca americana, a species of pokeweed.[https://web.archive.org/web/20091016220039/http://whqlibdoc.who.int/druginfo/INN_2001_list46.pdf WHO Drug Information] This is reflected by the 'paptox' in the drug's name.